Business
MEDICURE ANNOUNCES RESULTS OF 2022 AGM
MEDICURE ANNOUNCES RESULTS OF 2022 AGM Canada NewsWire WINNIPEG, MB...
About this update from Medicure Inc.
[{"type":"text","content":"\n \n \n \n MEDICURE ANNOUNCES RESULTS OF 2022 AGM\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n WINNIPEG, MB\n \n \n ,\n \n \n June 20, 2022\n \n \n /CNW/ - (\n \n June 20, 2022\n \n ) Medicure Inc. (\"\n \n Medicure\n \n \" or the \"\n \n Company\n \n \") (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in\n \n the United States\n \n market, is pleased to announce that the following individuals were elected as directors at its Annual General Meeting of shareholders held on\n \n June 16\n \n , 2022:  Dr.\n \n Albert Friesen\n \n ,\n \n Gerald McDole\n \n ,\n \n Brent Fawkes\n \n , Dr.\n \n Arnold Naimark\n \n ,\n \n Peter Quick\n \n and\n \n James Kinley\n \n .  In addition, the shareholders re-appointed Ernst & Young LLP, Chartered Accountants, as auditor of the Company.\n \n \n On behalf of the Board of Directors and management, Dr.\n \n Albert D. Friesen\n \n , CEO and Chair of the Board of Directors, stated, \"We want to thank\n \n Manon Harvey\n \n for her tenure as a director and are pleased to welcome\n \n James Kinley\n \n as the newest addition to the Board of Directors.\"\n \n \n \n About Medicure Inc.\n \n \n Medicure is a pharmaceutical company focused on the development and commercialization of therapies for the U.S. cardiovascular market. The present focus of the Company is the marketing and distribution of AGGRASTAT\n \n ®\n \n (tirofiban hydrochloride) injection and ZYPITAMAG\n \n ®\n \n (pitavastatin) tablets in\n \n the United States\n \n , where they are sold through the Company's U.S. subsidiary, Medicure Pharma Inc. Medicure also operates Marley Drug, Inc. (\"Marley Drug\"), a pharmacy located in\n \n North Carolina\n \n that offers an Extended Supply drug program serving all 50 states,\n \n Washington D.C.\n \n and\n \n Puerto Rico\n \n . Marley Drug\n \n ®\n \n is committed to improving the health status of its patients and the communities they serve while reducin...